Specific in vivo detection of V2R-positive metastatic ccRCC using a toxin-based PET radioligand

Background: The diagnosis of metastatic clear cell renal cell carcinoma (mccRCC) remains challenging due to the tumor's molecular heterogeneity, often resulting in low sensitivity and a high false-positive rate.In this study, we introduce and validate a new imaging modality for mccRCC based on the first radioligand targeting the type 2 vasopressin receptor (V2R) suitable for positron emission tomography (PET).V2R is ectopically expressed in mccRCC.This imaging approach utilizes [ 18 F]F-MQ232, a radiolabeled peptide derived from snake venom which exhibits high in vivo selectivity for V2R.Methods: The V2R-selective peptide MQ232 conjugated with either a cyanine 5 (Cy5) or a fluorine 18 ( 18 F) group were chemically synthetized.V2R mRNA was quantified and protein expression assessed by flow cytometry using Cy5-MQ232.The selectivity and tumor targeting ability of the modified MQ232 peptides were assessed using in vivo fluorescence imagery in tumor-bearing mice using CHO-V2R tumors with graded expression.Metabolic stability and PET pharmacokinetics of [ 18 F]F-MQ232 were assessed in rodents.Specific tumor targeting and imaging contrast were validated in vivo using V2R-expressing tumors.Results: [ 18 F]F-MQ232 is a highly relevant radioligand whose tumor uptake directly correlates with V2R expression levels in tissues, demonstrating its specificity to V2R-expressing tumors.Replacing the peptide moiety by an isoform unable to interact with V2R leads to a drastic decrease in the radioligand's tumor uptake, highlighting its origin in a specific, ligand/receptor type interaction between the MQ232 moiety and V2R.PET/CT imaging of Caki-1 xenografted mice demonstrated the ability of [ 18 F]F-MQ232 to allow specific detection of the tumor compartment associated with high tumor-to-background contrast.RT-qPCR screening of metastatic and non-metastatic ccRCC biopsies from patients confirms V2R expression.Conclusions: This work validates the V2R-targeting strategy in mccRCC using [ 18 F]F-MQ232 and demonstrates that human mccRCC tissues express V2R, confirming the suitability of this specific imaging technique for metastasis extension assessment.